Evidence map›Paper›PMID 42892842›Full record

ArticleDiabetes, obesity, and cardiometabolic CARE

Acceptability and Feasibility of a Primary Care Hypoglycemia Prevention Program: A Pilot Study.

Scott J Pilla, Marielle T Bugayong, Jose Amezcua Moreno, Mohammed S Abusamaan, Somnath Saha, Claire Snyder, Rozalina G McCoy, Alexandria Ratzki-Leewing, Anna R Kahkoska, Susan H Schrock and 2 more

Abstract read
In one paragraph

Article in Diabetes, obesity, and cardiometabolic CARE. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Scott J PillaDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID https://orcid.org/0000-0002-3292-9047
Marielle T BugayongDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Jose Amezcua MorenoDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Mohammed S AbusamaanDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Somnath SahaDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Claire SnyderDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Rozalina G McCoyDivision of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
Alexandria Ratzki-LeewingDivision of Gerontology, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD.
Anna R KahkoskaDepartment of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Susan H SchrockJohns Hopkins Community Physicians, Baltimore, MD.
Nestoras N MathioudakisDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Nisa M MaruthurDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Funding

Supplement to Effectiveness of Digital Versus In-Person Diabetes Prevention ProgramsR01DK125780 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MATHIOUDAKIS, NESTORAS N · 2020 to 2023
$3.0M
The PRIORITY Study: from PRedIctiOn to pReventIon of youth-onset TYpe 2 diabetesU01DK134975 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SHEELA NATESH MAGGE · 2023 to 2026
$1.9M
Implementation of a diabetes navIgator to Mitigate disPArities and improve CGM upTake and sustained use across the lifespan of T1D (IMPACT T1D)R01DK134955 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MATHIOUDAKIS, NESTORAS N, WOLF, RISA MICHELLE · 2022 to 2025
$1.8M
Utilizing islet autoantibody signatures for precision medicine in type 2 diabetesR01DK126825 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MARUTHUR, NISA M · 2021 to 2024
$1.8M
Challenges to Guideline-Recommended Diabetes Care in the United StatesR01DK139324 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Jung-Im Shin · 2025 to 2026
$1.4M
Program Development (Pilot) Core (Core B)P30AG097158 · NIA · UNIV OF MARYLAND, COLLEGE PARK · PI Jie Chen, Rozalina Grubina McCoy · 2025 to 2026
$1.3M
An intervention to enhance hypoglycemia communication and preventive action in primary careK23DK128572 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI PILLA, SCOTT · 2021 to 2024
$790k
Building a Real-World Evidence Base for Continuous Glucose Monitoring in Older Adults with DiabetesK01AG084971 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Anna Rachel Kahkoska · 2024 to 2026
$384k
Design and Pilot Test of A Prediabetes Digital Patient Activation ToolR03DK135898 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI TSENG, EVA · 2023 to 2024
$241k
Evaluating clinician communication around glycemic management and its health impact for people with diabetesR03DK144349 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI PILLA, SCOTT · 2025 to 2025
$233k
NIA NIH HHS K01 AG084971NIA NIH HHS P30 AG097158NIDDK NIH HHS K23 DK128572NIDDK NIH HHS R01 DK125780NIDDK NIH HHS R01 DK126825NIDDK NIH HHS R01 DK134955NIDDK NIH HHS R01 DK139324NIDDK NIH HHS R03 DK135898NIDDK NIH HHS R03 DK144349NIDDK NIH HHS U01 DK134975
6 · The paper itself

Abstract

objectiveHypoglycemia, a major cause of morbidity for people with diabetes, is underrecognized in primary care, leading to underuse of risk mitigation strategies. This study reports the development and acceptability/feasibility testing of the Hypoglycemia Prevention Program (HPP), an electronic health record-integrated toolkit for primary care. RESEARCH DESIGN AND

methodsThe HPP was developed through stakeholder engagement and included a pre-visit hypoglycemia history survey, primary care provider (PCP) hypoglycemia toolkit, and patient self-management handout. The HPP pilot study was a pre-post clinical trial at one primary care practice. Participants were adults with diabetes treated with insulin or sulfonylureas, their PCPs, and clinic staff. The primary outcome was acceptability; exploratory outcomes included pre- to postintervention change in PCP hypoglycemia prevention actions, self-reported hypoglycemia, and optional blinded 10-day continuous glucose monitoring (CGM).

resultsThe intervention was completed by 31 of 35 enrolled patients with diabetes (89%) for whom it triggered frequent hypoglycemia alerts. The intervention was rated acceptable or completely acceptable by 87% of patients and 100% of participating PCPs (

conclusionsA hypoglycemia prevention program designed for primary care is feasible to implement and acceptable to clinical and patient stakeholders, with evidence of improved hypoglycemia prevention efforts. Further efficacy evaluation is needed.

Identifiers

PMID42892842
PMCPMC13675405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.